Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

Boosting CGT access: a global consideration with wide-spanning benefits

Experts say wider patient access to CGTs hinges on further infrastructure developments and the movement of therapies into the community setting.

Latest news

J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout

J&J strikes this deal with Sail as the in vivo CAR-T space becomes increasingly crowded.

EU regulatory roundup: AbbVie, Pfizer & BioNTech and Incyte net approvals

Rinvoq, Comirnaty and Opzelura have all received their own EC approvals this week.

Sublingual semaglutide offered to UK practices despite Novo Nordisk concerns

Sublingual semaglutide, which does not hold marketing authorisation, is touted to minimise gastric issues.

Resilience and Lilly to increase US medicines production with $750m investment

The investment will support Resilience’s advanced manufacturing operations in Cincinnati.

European drug manufacturers under threat from proposed US supply chain bill

US efforts to scrutinise overseas pharmaceutical manufacturing could expose Europe’s dominant role in supplying FDA-approved innovator and biosimilar drugs, reshaping global biopharma supply chains.

miRecule and Rio Biofarma to develop RNA therapeutic delivery technologies

The collaboration seeks to develop delivery approaches that could make RNA therapeutics available to a broader tissue selection.

Australia approves first-in-class Niktimvo for later-line cGVHD

Niktimvo reduces the development, survival, and activity of monocyte-derived macrophages, which contribute to cGVHD inflammation and tissue fibrosis.